Many studies report that adiponectin has an antiatherogenic effects; in coronary atherosclerosis, NLRP3 expression in subcutaneous adipose tissue is negatively correlated with the serum adiponectin level (Bando et al., 2015). This evidence concerns the gene ADIPOQ and coronary atherosclerosis.